Literature DB >> 1846575

Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses.

M C Morale1, N Batticane, G Bartoloni, V Guarcello, Z Farinella, M G Galasso, B Marchetti.   

Abstract

The development of the thymus and the hypothalamic-pituitary-gonadal axis are linked by bidirectional hormonally mediated relationships. In the present study, the direct involvement of the neuropeptide LHRH in the maturation of the thymus and development of the cell-mediated and humoral immune responses were assessed after treatment of neonatal (from post-natal day 1-day 5) female rats with a potent LHRH-antagonist (LHRH-anta, p-Glu-D-Phe 2.6,Pro3-LHRH, 50 micrograms/rat), and the effects compared to those resulting from neonatal castration. Whereas in control animals the maturation of mitogenic potential in thymocyte cultures showed a progressive and age-dependent increase, reaching a maximal activity at 30 days of age and then decreasing after puberty onset, in LHRH-anta-treated rats, the thymocyte's proliferative response was completely blocked at 7 days of age and remained very low at each time interval studied, until 3 months of age. A similar effect of the LHRH-anta treatment on splenocyte cultures was measured. Moreover, a reduced percentage of the T-helper lymphocyte subpopulation followed LHRH-anta administration. By contrast, in neonatally castrated rats, blastogenic activity was significantly higher, compared to control cultures, at each stage studied. Treatment with LHRH-anta produced a significant decrease in thymus wt, an alteration of the maturational pattern characterized by a cellular monomorphism, reduced thymocyte volume, reduction of the cortical area, and depauperation of the epithelial microenvironment. Moreover, a morphometric analysis revealed a selective decrease in the large lymphoid cell population of the subcapsular cortex at 7 and 15 days. On the other hand, neonatal castration produced an opposite effect, leading to a marked hypertrophy of the cortical area, and counteracted the post-puberal thymus atrophy. When LHRH-anta-treated adult (3-month-old) rats were challenged with an antigenic stimulus (multiple sc injections of complete Freund adjuvant and BSA) and antibody (anti-BSA antibodies of the immunoglobulin G class) production measured in the serum after 15 days, a marked and significant decrease in immunoglobulin G levels was observed, compared to the values measured in untreated control. The described immune deficiencies in LHRH-anta-treated rats were associated with a clear inhibition of sexual maturation. This study clearly indicates that the blockade of central and peripheral LHRH receptors during a critical period for maturation of both hypothalamus-hypophyseal-gonadal axis and brain-thymus-lymphoid axis dramatically impairs immune system development, suggesting a potential role of the neuropeptide LHRH in the bidirectional programming of both neuroendocrine and immune functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846575     DOI: 10.1210/endo-128-2-1073

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Mast cells in the rat brain synthesize gonadotropin-releasing hormone.

Authors:  Mona H Khalil; Ann-Judith Silverman; Rae Silver
Journal:  J Neurobiol       Date:  2003-08

Review 2.  Role of gonadal hormones in programming developmental changes in thymopoietic efficiency and sexual diergism in thymopoiesis.

Authors:  Gordana Leposavic; Milica Perisic; Ivan Pilipovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Long-lasting effects of the prenatal blockade of gonadotropin-releasing hormone receptor in the rat thymus.

Authors:  V I Melnikova; N V Lifantseva; S N Voronova; L A Zakharova
Journal:  Dokl Biochem Biophys       Date:  2015-07-12       Impact factor: 0.788

4.  GnRH-I and GnRH-II have differential modulatory effects on human peripheral blood mononuclear cell proliferation and interleukin-2 receptor gamma-chain mRNA expression in healthy males.

Authors:  F Tanriverdi; D Gonzalez-Martinez; Y Hu; F Kelestimur; P M G Bouloux
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  Neuroendocrineimmunology (NEI) at the turn of the century: towards a molecular understanding of basic mechanisms and implications for reproductive physiopathology.

Authors:  B Marchetti; M C Morale; F Gallo; N Batticane; Z Farinella; M Cioni
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

6.  Cross-talk between luteinizing hormone-releasing hormone (LHRH) neurons and astroglial cells: developing glia release factors that accelerate neuronal differentiation and stimulate LHRH release from GT(1-1) neuronal cell line and LHRH neurons induce astroglia proliferation.

Authors:  F Gallo; M C Morale; R Avola; B Marchetti
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

7.  Association between radical prostatectomy and risk of herpes zoster.

Authors:  C-Y Hsu; P-R Chen; H-J Chen; J-A Liang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-18       Impact factor: 3.267

8.  Characterization of gene expression in resting and activated mast cells.

Authors:  H Chen; M Centola; S F Altschul; H Metzger
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

9.  The immune system response during development and progression of carcinogen-induced rat mammary tumors: prevention of tumor growth and restoration of immune system responsiveness by thymopentin.

Authors:  F Gallo; M C Morale; D Sambataro; Z Farinella; U Scapagnini; B Marchetti
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

10.  Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA.

Authors:  C C Maier; B Marchetti; R D LeBoeuf; J E Blalock
Journal:  Cell Mol Neurobiol       Date:  1992-10       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.